These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Renal replacement therapy by hemodialysis: an overview]. Jacobs C Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Heintz BH; Matzke GR; Dager WE Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464 [TBL] [Abstract][Full Text] [Related]
4. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate? O'Shea S; Duffull S; Johnson DW Semin Dial; 2009; 22(3):225-30. PubMed ID: 19386073 [TBL] [Abstract][Full Text] [Related]
5. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment. Lalonde RL; Wagner JA Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736 [TBL] [Abstract][Full Text] [Related]
6. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis. Velenosi TJ; Urquhart BL Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255 [TBL] [Abstract][Full Text] [Related]
8. Drug removal by plasmapheresis: an evidence-based review. Ibrahim RB; Liu C; Cronin SM; Murphy BC; Cha R; Swerdlow P; Edwards DJ Pharmacotherapy; 2007 Nov; 27(11):1529-49. PubMed ID: 17963462 [TBL] [Abstract][Full Text] [Related]
9. [Renal function and pharmacotherapy in children]. Jovanović O Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796 [TBL] [Abstract][Full Text] [Related]
10. Drug dosing adjustments in patients with chronic kidney disease. Munar MY; Singh H Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141 [TBL] [Abstract][Full Text] [Related]
11. [Dose-response relationship: relevance for medical practice]. Klinkhardt U; Harder S Med Klin (Munich); 2000 May; 95(1 Spec No):9-14. PubMed ID: 10851842 [TBL] [Abstract][Full Text] [Related]
12. Improving outcomes in hemodialysis patients: the need for well-designed clinical trials. Toto RD Am J Kidney Dis; 2008 Sep; 52(3):400-2. PubMed ID: 18725012 [No Abstract] [Full Text] [Related]
13. Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy. Mueller BA; Smoyer WE Clin Pharmacol Ther; 2009 Nov; 86(5):479-82. PubMed ID: 19844225 [TBL] [Abstract][Full Text] [Related]
14. The impact of continuous renal replacement therapy on drug therapy. Susla GM Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069 [TBL] [Abstract][Full Text] [Related]
15. [Use of drugs in patients with renal failure (author's transl)]. Díes F Rev Invest Clin; 1979; 31(3):199-209. PubMed ID: 523855 [No Abstract] [Full Text] [Related]
16. Drug dosing in patients with impaired renal function. Brater DC Clin Pharmacol Ther; 2009 Nov; 86(5):483-9. PubMed ID: 19626002 [TBL] [Abstract][Full Text] [Related]
17. Emergency hemodialysis in the management of intoxication. Satar S; Alpay NR; Sebe A; Gokel Y Am J Ther; 2006; 13(5):404-10. PubMed ID: 16988535 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic studies of Minocycline in patients with chronic kidney failure either treated or not treated by hemodialysis]. Devulder B; Cuvelier D; Tacquet A Lille Med; 1974 Mar; 19(3):287-92. PubMed ID: 4612277 [No Abstract] [Full Text] [Related]